Noted as the first physician to be a private equity investor in health care, Mitchell Blutt served as an executive partner at JPMorgan Partners prior to founding Consonance Capital, where he serves as CEO. Mitchell Blutt’s New York-based company invests in private health care firms situated in the lower middle market.
Pennsylvania-headquartered KEPRO was one of the companies in which Consonance Capital invested. KEPRO was founded by physicians in 1985 to provide care management and quality improvement solutions to lessen the unwarranted use of health care resources and improve patient outcome. Consonance Capital invested in KEPRO in 2014 and helped the company grow both organically and through acquisition.
With Consonance Capital’s investment, KEPRO purchased APS Healthcare, increased its national presence, added new customers, and introduced new services. Since its founding, KEPRO has helped 20 million people live healthier lives.
In May 2017, Consonance Capital announced that it had sold KEPRO, with terms undisclosed.
2017 Population Health Summit
A pioneer in the field of healthcare investing, Dr. Mitchell Blutt holds a degree from the University of Pennsylvania School of Medicine. The first medical doctor in the healthcare investment business, Mitchell Blutt currently applies his expertise as the CEO of Consonance Capital and he is also a member of the New York Academy of Medicine.
The New York Academy of Medicine is a public health organization that specializes in urban health advocacy. Founded in 1847, the organization actively engages in research and policy studies in addition to other programming initiatives and events for those engaged in the public health professions.
One such event, the 2017 Population Health Summit, is scheduled for December 11, 2017, at the academy’s facility in New York City. The New York State Health Foundation is sponsoring the summit, which focuses on population health and the many factors that can affect it. For example, past workshops have addressed the importance of coordination between the health care and social service sectors as well as the non-medical determinants of a population’s overall health. Additional information on this year’s event, which is designed as a retrospective on the successes and challenges of all four past summits, can be found at www.nyam.org.
New York Academy of Medicine
Mitchell Blutt, MD, is a pioneer in the private healthcare sector, the first doctor to successfully transition from practicing clinical medicine to a role as a professional healthcare investor. Now serving as CEO of Consonance Capital in New York City, Mitchell Blutt, MD is involved in a number of health-related organizations, including the New York Academy of Medicine.
For 22 years, the New York Academy of Medicine has awarded the Rudin Glaucoma Prize to physicians and researchers who demonstrate excellence in studying glaucoma as evidenced by their high-level contributions to peer-reviewed scientific journals. For the 2017 calendar year, the academy chose Mary Kelly, PhD, of Oregon Health & Science University as its winner, recognizing her paper titled, “Induced Pluripotent Stem Cells Restore Function in a Human Cell Loss Model of Open-Angle Glaucoma.”
The groundbreaking research discussed in this article is the first to show that stem cells can be used to deal with the baseline biological causes of glaucoma. Standard treatment manages the symptoms, but the use of stem cells could potentially give doctors a way to reverse the condition instead.
Wharton School of Business
Prior to becoming a professor at Weill Cornell Medical College in New York, New York, Mitchell Blutt attended the University of Pennsylvania School of Medicine where he earned his MD. Mitchell Blutt also attended the Wharton School of Business at the University of Pennsylvania where he earned his MBA degree.
The Wharton School of Business MBA program at the University of Pennsylvania features several different subject formats that allow you to receive an MBA that fits with your individual career goals. The MBA program offers 19 different majors, ranging from subjects like business analytics and entrepreneurial management to marketing and health care management.
The MBA program in Health Care Management, overseen by the Leonard Davis Institute of Health Economics, combines professional and academic development to give students a wide range of knowledge and skills in areas that include insurers, hospitals, pharmaceutical firms, and consulting firms. Health Care Management participants also learn skills that can be used in managed care organizations, group practices, and government agencies.